ZOMETA® Prescribing Information – Summary Of European Product Characteristics
Home


About ZOMETA

ZOMETA Patient Case Studies

Zometa Dosing & Administration

ZOMETA Safety & Tolerability

ZOMETA Clinical News

ZOMETA For Your Patients

Professional Resource Center

ZOMETA Around the World
Videos
View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

 
European Summary of Product Characteristics
For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics
 
European Summary of Product Characteristics
 

The information below is provided in Portable Document Format (PDF). To view and print these documents, Adobe® Acrobat® Reader™ is required. If you need to download the free Adobe Acrobat Reader, click here.

ZOMETA® 4 mg powder and solvent for solution for infusion

ZOMETA 4 mg/5 ml concentrate for solution for infusion